An author of a study in the May 2021 issue of The American Journal of Managed Care® describes how the COVID-19 pandemic, the aging of America, and already-existing workforce shortages will further threaten the dual-eligible population unless policy makers reform scope-of-practice laws.
Triple forces are combining to create a crisis for the nation’s dual-eligible beneficiaries—that is, individuals who are covered under both Medicare and Medicaid. They tend to have multiple, chronic, costly medical conditions and have very low incomes.
In the May issue of The American Journal of Managed Care®, Wendy Y. Xu, PhD; Sheldon M. Retchin, MD, MSPH; and Peter Buerhaus, PhD, RN, published a study showing how states with the most restrictive scope-of-practice laws have an inadequate supply of primary care clinicians to serve areas with a high concentration of these vulnerable beneficiaries.
In this episode of Managed Care Cast, Xu describes how the COVID-19 pandemic, the aging of America, and already-existing workforce shortages will further threaten this population unless policy makers reform scope-of-practice laws.
Listen above or through one of these podcast services:
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More